PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS
- 5 November 1983
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 322 (8358), 1043-1046
- https://doi.org/10.1016/s0140-6736(83)91036-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Is Vancomycin Overpriced?New England Journal of Medicine, 1983
- Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitisInfection, 1982
- The Effect of Metronidazole and Sulfasalazine on the Fecal Flora in Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1981
- Lack of Evidence for Cancer Due to Use of MetronidazoleNew England Journal of Medicine, 1979
- Relapse of Pseudomembranous Colitis after Vancomycin TherapyNew England Journal of Medicine, 1979
- Antibiotic-Associated Pseudomembranous ColitisClinical Infectious Diseases, 1979
- ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISThe Lancet, 1978
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978
- Excretion of Metronidazole in Human BileScandinavian Journal of Gastroenterology, 1977
- ANTIBIOTIC-INDUCED COLITIS IMPLICATION OF A TOXIN NEUTRALISED BY CLOSTRIDIUM SORDELLII ANTITOXINThe Lancet, 1977